Ranexa and Seizures: Self-Controlled Risk Interval (SCRI) Design

Project Title Ranexa and Seizures: Self-Controlled Risk Interval (SCRI) Design
Description

This report had two goals: 1) to compare the baseline characteristics of ranolazine and beta blockers users and 2) to utilize a self-controlled risk interval study design to estimate the risk of seizure events within specified risk and control windows for ranolazine users, and those with concomitant use of ranolazine and CYP3 inhibitors.

Link
Published Date
Friday, January 4, 2019
Category
Final Results and Reports